Helix BioPharma Announces Fiscal 2026 Year-End Results

TSX Futures Slip as Oil Rebound Renews Inflation Concerns attack in the Strait of Hormuz underscored supply risks. Energy-driven inflation concerns have weighed on major banks since the start of the US-Iran war by raising the risk of inte H impact | EARNINGS | Oct 30, 2026, 12:44 PM UTC

Federal Realty Q3 Core FFO Rises 5.6%; Raises 2026 Guidance Federal Realty Investment Trust reported third-quarter Nareit and Core FFO of $163.0 million, or $1.87 per diluted share, versus $153.0 million, or $1.77 per diluted share, in Q3 2 M impact | EARNINGS | Oct 30, 2026, 12:44 PM UTC

ExxonMobil and Chevron Top Q3 Estimates on Higher Prices and Strong Output Both oil majors reported better-than-expected quarterly results Friday, attributed to higher prices and strong output. M impact | EARNINGS | Oct 30, 2026, 12:41 PM UTC

Intel Shares Slide as Weaker Q4 Outlook Overshadows Data Center Growth Intel reported third-quarter sales of $16.5 billion and non-GAAP EPS of $0.52, then issued a weaker fourth-quarter outlook. A factory shutdown, PC weakness and supply constraints w H impact | EARNINGS | Oct 30, 2026, 12:36 PM UTC

First Abu Dhabi Bank Pjsc earnings above expectations at 0.50 AED First Abu Dhabi Bank Pjsc (NBAD) released earnings per share at 0.50 AED, compared to market expectations of 0.47 AED. H impact | EARNINGS | Oct 30, 2026, 12:29 PM UTC

AbbVie Raises FY26 Adjusted EPS Outlook; Boosts Dividend 5.2% AbbVie raised its adjusted earnings guidance for full-year 2026 while reporting third-quarter results. It also boosted its dividend by 5.2%. H impact | EARNINGS | Oct 30, 2026, 12:20 PM UTC

Helix BioPharma Announces Fiscal 2026 Year-End Results

Related stories